首页> 外文OA文献 >P859 Association of immunopharmacodynamic responses of imprime PGG plus pembrolizumab with clinical benefit in metastatic triple negative breast cancer (TNBC) subjects failing front-line chemotherapy

【2h】

P859 Association of immunopharmacodynamic responses of imprime PGG plus pembrolizumab with clinical benefit in metastatic triple negative breast cancer (TNBC) subjects failing front-line chemotherapy

机译：P859免疫制药权答案的关联PGG Plus Pembrolizumab在转移性三重阴性乳腺癌（TNBC）受试者失败前线化疗中的临床益处

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nadine Ottoson; Nandita Bose; Anissa Chan; Xiaohong Qiu; Ben Harrison; Richard Walsh; Paulette Mattson; Michele Gargano; Joanna Cox; Michael Chisamore; Mark Uhlik; Jeremy Graff;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. P859?Association of immunopharmacodynamic responses of imprime PGG plus pembrolizumab with clinical benefit in metastatic triple negative breast cancer (TNBC) subjects failing front-line chemotherapy [J] . Nadine Ottoson, Nandita Bose, Anissa Chan, Journal for ImmunoTherapy of Cancer . 2020,第Suppla1期

机译：P859？Implime PGG Plus Pembolizumab与临床益处在转移性三重阴性乳腺癌（TNBC）受试者失败前线化疗
2. Response and clinical benefit assessment of the combination of the dectin-1 agonist imprime PGG and anti-PD-1 pembrolizumab in chemotherapy-resistant metastatic triple negative breast cancer (TNBC) [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：响应和临床效益评估Dectin-1激动剂PGG和抗PD-1 Pembrolizumab在化疗抗性转移性三重阴性乳腺癌（TNBC）中的组合
3. P862?Clinical benefit potentially evident with immunopharmacodynamic responses in prior-checkpoint failed metastatic melanoma patients treated with imprime PGG and pembrolizumab [J] . Anissa Chan, Nandita Bose, Nandita Bose, Journal for ImmunoTherapy of Cancer . 2020,第Suppla1期

机译：P862？在先前检查点中的免疫制药力反应可能明显潜在的临床益处失败的转移性黑色瘤患者，用英寸PGG和PEMBROLIZUAB治疗
4. Effect of curcumin on NF-κB P105/50 expression on triple-negative breast cancer (TNBC) and its possible mechanism of action [C] . Retno Murwanti, Eva Kholifah, B. S. Ari Sudarmanto, International Conference on Biological Science . 2020

机译：姜黄素对三重阴性乳腺癌（TNBC）对NF-κBP105/ 50表达的影响及其动作机制
5. The Attenuating Effects of 1,2,3,4,6-Penta-O-Galloyl-β-D Glucose (PGG) on the Inflammatory Cytokines Release in TNF-α-activated Triple Negative Breast Cancer (TNBC) Cells [D] . Alghamdi, Sumiah. 2019

机译：1,2,3,4,6-五核苷酸-β-D葡萄糖（PGG）对TNF-α-活化的三阴性乳腺癌（TNBC）细胞炎症细胞因子释放的衰减效应
6. Excellent Response to Atezolizumab After Clinically Defined Hyperprogression Upon Previous Treatment With Pembrolizumab in Metastatic Triple-Negative Breast Cancer: A Case Report and Review of the Literature [O] . Dongfeng Feng, Yaping Guan, Mingguo Liu, 2021

机译：在临床定义的超出以前在转移三重阴性乳腺癌治疗后临床定义过唑粒子后对atezolizumab的良好反应：案例报告和对文献的审查
7. P862 Clinical benefit potentially evident with immunopharmacodynamic responses in prior-checkpoint failed metastatic melanoma patients treated with imprime PGG and pembrolizumab [O] . Anissa Chan, Nandita Bose, Nadine Ottoson, 2020

机译：P862临床益处可能在先前检查点中的免疫力学响应可能明显，转移性的黑色瘤患者患者患者患者进行了缩写的pgg和pembrozumab

相关主题

P859 Association of immunopharmacodynamic responses of imprime PGG plus pembrolizumab with clinical benefit in metastatic triple negative breast cancer (TNBC) subjects failing front-line chemotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅